β-Catenin mutations and nuclear accumulation during progression of rat stomach adenocarcinomas

Cancer Science

Volumn 94, Issue 12, 2003, Pages 1046-1051

  Tsukamoto, Tetsuya ^a   Yamamoto, Masami ^a   Ogasawara, Naotaka ^a   Ushijima, Toshikazu ^b   Nomoto, Tomoko ^b   Fujita, Hirofumi ^c   Matsushima, Taijiro ^c   Nozaki, Koji ^a   Cao, Xueyuan ^a   Tatematsu, Masae ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c Japan Bioassay Research Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DNA; GLYCINE; METHYLNITRONITROSOGUANIDINE; SERINE; THREONINE; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CELL MEMBRANE; CELL NUCLEUS; CELL POLARITY; COLORECTAL CANCER; CONTROLLED STUDY; CYTOPLASM; DNA DETERMINATION; EXON; FISHER EXACT TEST; FREQUENCY ANALYSIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MICRODISSECTION; MORPHOLOGY; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; STOMACH ADENOCARCINOMA; STOMACH CARCINOGENESIS; STOMACH MUCOSA; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ANIMALS; BASE SEQUENCE; BETA CATENIN; CARCINOGENS; CELL NUCLEUS; DISEASE PROGRESSION; IMMUNOHISTOCHEMISTRY; MALE; METHYLNITRONITROSOGUANIDINE; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RATS; STOMACH NEOPLASMS;

EID: 0345768487     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2003.tb01399.x     Document Type: Article

References (32)

1. El-Rifai W, Powell SM. Molecular biology of gastric cancer. Semin Radiat Oncol 2002; 12: 128-40.
2. Soussi T. The p53 tumor suppressor gene: from molecular biology to clinical investigation. Ann N Y Acad Sci 2000; 910: 121-37; discussion 37-9.
3. Strathdee G. Epigenetic versus genetic alterations in the inactivation of E-cadherin. Semin Cancer Biol 2002; 12: 373-9.
4. Yokozaki H, Yasui W, Tahara E. Genetic and epigenetic changes in stomach cancer. Int Rev Cytol 2001; 204: 49-95.
5. Polakis P. Wnt signaling and cancer. Genes Dev 2000; 14: 1837-51.
6. Candidus S, Bischoff P, Becker KF, Hofler H. No evidence for mutations in the alpha- and beta-catenin genes in human gastric and breast carcinomas. Cancer Res 1996; 56: 49-52.
7. Sasaki Y, Morimoto I, Kusano M, Hosokawa M, Itoh F, Yanagihara K, Imai K, Tokino T. Mutational analysis of the beta-catenin gene in gastric carcinomas. Tumour Biol 2001; 22: 123-30.
8. Tong JH, To KF, Ng EK, Lau JY, Lee TL, Lo KW, Leung WK, Tang NL, Chan FK, Sung JJ, Chung SC. Somatic beta-catenin mutation in gastric carcinoma-an infrequent event that is not specific for microsatellite instability. Cancer Lett 2001; 163: 125-30.
9. Woo DK, Kim HS, Lee HS, Kang YH, Yang HK, Kim WH. Altered expression and mutation of beta-catenin gene in gastric carcinomas and cell lines. Int J Cancer 2001; 95: 108-13.
10. Ebert MP, Fei G, Kahmann S, Muller O, Yu J, Sung JJ, Malfertheiner P. Increased beta-catenin mRNA levels and mutational alterations of the APC and beta-catenin gene are present in intestinal-type gastric cancer. Carcinogenesis 2002; 23: 87-91.
11. Clements WM, Wang J, Sarnaik A, Kim OJ, MacDonald J, Fenoglio-Preiser C, Groden J, Lowy AM. Beta-catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res 2002; 62: 3503-6.
12. Ohene-Abuakwa Y, Noda M, Perenyi M, Kobayashi N, Kashima K, Hattori T, Pignatelli M. Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer. J Pathol 2000; 192: 433-9.
13. Miyazawa K, Iwaya K, Kuroda M, Harada M, Serizawa H, Koyanagi Y, Sato Y, Mizokami Y, Matsuoka T, Mukai K. Nuclear accumulation of beta-catenin in intestinal-type gastric carcinoma: correlation with early tumor invasion. Virchows Arch 2000; 437: 508-13.
14. Sugimura T, Fujimura S. Tumour production in glandular stomach of rat by N-methyl-N′-nitro-N-nitrosoguanidine. Nature 1967; 216: 943-4.
15. Ohgaki H, Sugimura T. Experimental gastric cancer. In: Sugimura T, Sasako M, editors. Gastric cancer. New York: Oxford University Press; 1997. p. 73-86.
16. Tatematsu M, Takahashi M, Fukushima S, Hananouchi M, Shirai T. Effects in rats of sodium chloride on experimental gastric cancers induced by N-methyl-N-nitro-N-nitrosoguanidine or 4-nitroquinoline-1-oxide. J Natl Cancer Inst 1975; 55: 101-6.
17. Tatematsu M, Furihata C, Hirose M, Shirai T, Ito N. Changes in pepsinogen isozymes in stomach cancers induced in Wistar rats by N-methyl-N′-nitro-N-nitrosoguanidine and in transplantable gastric carcinoma (SG2B). J Natl Cancer Inst 1977; 58: 1709-16.
18. Tatematsu M, Katsuyama T, Fukushima S, Takahashi M, Shirai T, Ito N, Nasu T. Mucin histochemistry by paradoxical concanavalin A staining in experimental gastric cancers induced in Wistar rats by N-methyl-N-nitro-N-nitrosoguanidine or 4-nitroquinoline 1-oxide. J Natl Cancer Inst 1980; 64: 835-43.
19. Ohgaki H, Kawachi T, Matsukura N, Morino K, Miyamoto M, Sugimura T. Genetic control of susceptibility of rats to gastric carcinoma. Cancer Res 1983; 43: 3663-7.
20. Tatematsu M, Furihata C, Katsuyama T, Mera Y, Inoue T, Matsushima T, Ito N. Immunohistochemical demonstration of pyloric gland-type cells with low-pepsinogen isozyme 1 in preneoplastic and neoplastic tissues of rat stomachs treated with N-methyl-N′-nitro-N-nitrosoguanidine. J Natl Cancer Inst 1987; 78: 771-7.
21. Hirayama Y, Wakazono K, Yamamoto M, Kitano M, Tatematsu M, Nagao M, Sugimura T, Ushijima T. Rare mutations of p53, Ki-ras, and beta-catenin genes and absence of K-sam and c-erbB-2 amplification in N-methyl-N′-nitro-N-nitrosoguanidine-induced rat stomach cancers. Mol Carcinog 1999; 25: 42-7.
22. Yamamoto M, Tsukamoto T, Sakai H, Shirai N, Ohgaki H, Furihata C, Donehower LA, Yoshida K, Tatematsu M. p53 knockout mice (-/-) are more susceptible than (+/-) or (+/+) mice to N-methyl-N-nitrosourea stomach carcinogenesis. Carcinogenesis 2000; 21: 1891-7.
23. Tsukamoto T, Tanaka H, Fukami H, Inoue M, Takahashi M, Wakabayashi K, Tatematsu M. More frequent β-catenin gene mutations in adenomas than in aberrant crypt foci or adenocarcinomas in the large intestines of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-treated rats. Jpn J Cancer Res 2000; 91: 792-6.
24. Park WS, Oh RR, Park JY, Lee SH, Shin MS, Kim YS, Kim SY, Lee HK, Kim PJ, Oh ST, Yoo NJ, Lee JY. Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer. Cancer Res 1999; 59: 4257-60.
25. Koesters R, Hans MA, Benner A, Prosst R, Boehm J, Gahlen J, Doeberitz MK. Predominant mutation of codon 41 of the beta-catenin proto-oncogene in rat colon tumors induced by 1,2-dimethylhydrazine using a complete carcinogenic protocol. Carcinogenesis 2001; 22: 1885-90.
26. Takahashi M, Fukuda K, Sugimura T, Wakabayashi K. Beta-catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res 1998; 58: 42-6.
27. Dashwood RH, Suzui M, Nakagama H, Sugimura T, Nagao M. High frequency of beta-catenin (ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat. Cancer Res 1998; 58: 1127-9.
28. Blum CA, Xu M, Orner GA, Fong AT, Bailey GS, Stoner GD, Horio DT, Dashwood RH. Beta-catenin mutation in rat colon tumors initiated by 1,2-dimethylhydrazine and 2-amino-3-methylimidazo[4,5-f]quinoline, and the effect of post-initiation treatment with chlorophyllin and indole-3-carbinol. Carcinogenesis 2001; 22: 315-20.
29. Suzui M, Ushijima T, Dashwood RH, Yoshimi N, Sugimura T, Mori H, Nagao M. Frequent mutations of the rat beta-catenin gene in colon cancers induced by methylazoxymethanol acetate plus 1-hydroxyanthraquinone. Mol Carcinog 1999; 24: 232-7.
30. Suzui M, Sugie S, Mori H, Okuno M, Tanaka T, Moriwaki H. Different mutation status of the beta-catenin gene in carcinogen-induced colon, brain, and oral tumors in rats. Mol Carcinog 2001; 32: 206-12.
31. Ilyas M, Tomlinson IP, Rowan A, Pignatelli M,Bodmer WF. Beta-catenin mutations in cell lines established from human colorectal cancers. Proc Natl Acad Sci USA 1997; 94: 10330-4.
32. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997; 275: 1787-90.